Post by jb on Dec 12, 2022 15:58:39 GMT
Next year Dr. Frost turns 87, by all accounts a good run and one that should be applauded. Within the portfolio of the good Dr. I haven't seen a partnership with Ponce de Lone or any other "Fountain of Youth" companies.
As it relates to investing, it would be irresponsible to think that the age of the principal shareholder doesn't play a role as to the health of a company and ultimately the share price. To that extent, a question I asked my broker last week was, " what happens to the share price of OPK if Dr. Frost is no longer with us". His answer was "I didn't know". So I ask the collective brain trust of this board, as we look to the new year knowing Dr. Frost turns 87 and he hasn't partnered with Ponce de Leon, what happens to the stock price when the inevitable happens.
As it relates to investing, it would be irresponsible to think that the age of the principal shareholder doesn't play a role as to the health of a company and ultimately the share price. To that extent, a question I asked my broker last week was, " what happens to the share price of OPK if Dr. Frost is no longer with us". His answer was "I didn't know". So I ask the collective brain trust of this board, as we look to the new year knowing Dr. Frost turns 87 and he hasn't partnered with Ponce de Leon, what happens to the stock price when the inevitable happens.